Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 263(34): 17905-8, 1988 Dec 05.
Article in English | MEDLINE | ID: mdl-3056930

ABSTRACT

Retroviruses code for a virus-specific protease which is essential for polyprotein processing and viral infectivity. The human immune deficiency virus-1 protease is an aspartic protease of 9 kDa which was synthesized by recombinant DNA technology and arises by autocatalytic processing from a polyprotein precursor which has recently been demonstrated by use of a protease-specific monoclonal antibody. The protease was shown to form dimers. Here we demonstrate that synthetic peptides can be used as both model substrates as well as inhibitors for investigation of the protease. 14 synthetic peptides, 7-18 amino acids in length, containing putative protease cleavage sites of the viral polyprotein gag and pol precursors, have been analyzed with the partially purified protease by the use of high performance liquid chromatography. In seven cases, where cleavage was observed, the length of the peptides did not significantly influence the cleavage efficiencies, heptapeptides being large enough as model substrates. No cleavage was observed with a protein preparation purified in parallel from control bacteria not expressing the human immune deficiency virus-1 protease. The protease was not only able to cut next to a proline but also between other peptides indicating that the proline is not a prerequisite. Three peptides with either reduced bonds at the cleavage site or a substitution by statin were inhibitory while another uncleaved substrate was not. The usefulness of small model substrates for characterization of the protease is further demonstrated by determination of a kinetic optimum pH (3.5-5.5) and incubation temperature (37 degrees C).


Subject(s)
HIV-1/enzymology , Peptide Hydrolases/metabolism , Escherichia coli/genetics , Kinetics , Peptide Fragments/isolation & purification , Peptide Hydrolases/genetics , Peptide Hydrolases/isolation & purification , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Substrate Specificity
2.
Eur J Biochem ; 175(3): 549-56, 1988 Aug 15.
Article in English | MEDLINE | ID: mdl-3409882

ABSTRACT

A full-length cDNA for bovine heart fatty-acid-binding protein (H-FABP) was cloned from a lambda gt11 cDNA library established from bovine heart muscle. The cDNA sequence shows an open reading frame coding for a protein with 133 amino acids. Colinearity with the amino acid sequences of four tryptic peptides was asserted. H-FABP isolated from bovine heart begins with an N-acetylated valine residue, however, as derived from analysis of the tryptic, amino-terminal-blocked peptide and the molecular mass of the peptide obtained via secondary-ion mass spectrometry. The molecular mass of the total protein is 14673 Da. Bovine H-FABP is 89% homologous to rat H-FABP and 97% homologous to the bovine mammary-derived growth-inhibition factor described recently by Böhmer et al. [J. Biol. Chem. 262, 15137-15143 (1987)]. Significant homologies were also found with bovine myelin protein P2 and murine adipocyte protein p422. Secondary-structure predictions were proposed for these proteins, based on computer analysis, which reveal striking similarities.


Subject(s)
Carrier Proteins/genetics , Cloning, Molecular , DNA/biosynthesis , Myocardium/metabolism , Neoplasm Proteins , Nerve Tissue Proteins , Acetylation , Amino Acids/analysis , Animals , Base Sequence , Cattle , Chromatography, High Pressure Liquid , Computers , DNA/analysis , Fatty Acid-Binding Protein 7 , Fatty Acid-Binding Proteins , Molecular Sequence Data , Peptides/analysis , Protein Biosynthesis , Protein Conformation , RNA, Messenger/analysis , Rats , Sequence Homology, Nucleic Acid
3.
EMBO J ; 7(6): 1785-91, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3049075

ABSTRACT

Retroviruses code for a specific protease which is essential for polyprotein precursor processing and viral infectivity. The HIV-specific protease has been predicted to be an aspartic protease which is located at the amino terminus of the pol gene. We have prepared several constructs for bacterial expression of the protease. Two of them span the whole protease region and result in its autocatalytic activation. Analysis of the dynamics of this activation indicates a two-step process which starts at the carboxy terminus and ends at the amino terminus of the protease. The activated protease is a molecule of 9 kd as evidenced by monoclonal antibody in immunoblot analysis. A construct in which the carboxy terminus of the protease is deleted results in a stable, enzymatically inactive 27-kd protein which proved useful as substrate since it contains one of the predicted cleavage sites. The stability of this protein indicates that the carboxy-terminal sequences of the protease are essential for its activity and its autocatalytic activation. The protease which is very hydrophobic was solubilized by acetone treatment and passaged over ultrogel and propylagarose columns for partial purification. It elutes as a dimer and tends to aggregate. It is inhibited by pepstatin A in agreement with its expected active site and its theoretical classification as aspartic protease. Cleavage of the gag precursor results in the mature capsid protein, p17. The protease does not, however, cleave the denatured 27-kd substrate or the denatured gag precursor. Therefore its specificity appears to be not solely sequence- but also conformation-dependent. This property needs to be taken into account for the development of protease inhibitors for therapy of AIDS.


Subject(s)
Endopeptidases/isolation & purification , HIV/enzymology , Recombinant Fusion Proteins/isolation & purification , Recombinant Proteins/isolation & purification , Retroviridae Proteins/isolation & purification , Antibodies, Monoclonal/immunology , Endopeptidases/immunology , Endopeptidases/metabolism , Escherichia coli/metabolism , Gene Products, gag , HIV/immunology , HIV Antibodies/immunology , HIV Protease , Pepstatins/pharmacology , Protease Inhibitors , Protein Precursors/metabolism , Protein Processing, Post-Translational , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/metabolism , Retroviridae Proteins/immunology , Retroviridae Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...